Position in MYGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,033,567
-$3,304 QoQ
Shares Held
181,010
+7.4% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 196 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $34,825,977 across 16 Diagnostics & Research names. MYGN ranks #9 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
72,182 | $10,829,464 | |
| 2 | BLLN |
BillionToOne, Inc.
|
46,300 | $5,555,074 | |
| 3 | A |
Agilent Technologies, Inc.
|
38,500 | $5,113,955 | |
| 4 | CDNA |
CareDx, Inc.
|
82,772 | $2,359,002 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
|
109,300 | $2,242,836 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
3,900 | $2,053,115 | |
| 7 | PSNL |
Personalis, Inc.
|
130,294 | $1,745,939 | |
| 8 | WAT |
Waters Corp /De/
|
4,051 | $1,519,287 |
All Filings in MYGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,033,567 | 181,010 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $1,036,871 | 168,597 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,168,425 | 161,608 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $56,236 | 10,591 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,191,559 | 134,336 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $899,952 | 32,857 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $364,559 | 19,047 | Shares | Sole | 2024-10-21 | |
| 2023-09-30 | $1,362,180 | 84,924 | Shares | Sole | 2024-10-21 | |
| 2023-06-30 | $1,697,193 | 73,218 | Shares | Sole | 2024-10-21 | |
| 2022-12-31 | $667,879 | 46,029 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||